RodolfoAlejandroMD

Endocrinology • Miami, FL

Diabetes, Lipid Metabolism

Professor, Medicine, University of Miami School of Medicine

Join to view full profile

Dr. Alejandro is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Alejandro's full profile

Already have an account?

Office
1450 NW 10th Ave
Miami, FL 33136
Phone+1 305-243-6145

Fax+1 305-243-9927

Education & Training

University of Miami/Jackson Health SystemFellowship, Endocrinology, Diabetes, and Metabolism, 1979 - 1982
University of Puerto Rico School of MedicineClass of 1975

Certifications & Licensure

FL State Medical License 1979 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression Start of enrollment: 2000 Jul 01
Completed
Phase 2
Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen Start of enrollment: 2000 Mar 01
Completed
Phase 2
Islet Cell Transplantation Alone in Patients With Type 1 Diabetes Mellitus: Steroid-Free Immunosuppression Start of enrollment: 2000 Dec 01
Active, not recruiting
Phase 2
Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation Start of enrollment: 2000 Dec 01
Completed
Phase 2
Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus Start of enrollment: 2000 Dec 01
Terminated
Phase 2
Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation Start of enrollment: 2005 Jul 01
Completed
Phase 2
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss Start of enrollment: 2009 Jan 01
Recruiting
Not Applicable
Long Term Follow up of Recipients of Functional Islet Allografts Start of enrollment: 2013 Mar 01
Recruiting
Long Term Surveillance of Islet Transplant Recipients Following Complete Graft Loss Start of enrollment: 2008 Dec 01
Recruiting
Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation Start of enrollment: 2009 Apr 01
Completed
Allogeneic Islet Cells Transplanted Onto the Omentum Start of enrollment: 2014 Sep 01
Completed
Phase 1, Phase 2
Join now to see all

Publications & Presentations

PubMed

4 citations
HLA-B Matching Prolongs Allograft Survival in Islet Cell Transplantation.
Joana R N Lemos, David A Baidal, Raffaella Poggioli, Virginia Fuenmayor, Carmen Chavez
Cell Transplantation. 2023-08-01
4 citations
Predictive Value of C-Peptide Measures for Clinical Outcomes of β-Cell Replacement Therapy in Type 1 Diabetes: Report From the Collaborative Islet Transplant Registry ...
David A Baidal, Cassandra M Ballou, Michael R Rickels, Thierry Berney, Francois Pattou
Diabetes Care. 2023-04-01
1 citations
Impact of GAD65 and IA2 autoantibodies on islet allograft survival.
Joana R N Lemos, Raffaella Poggioli, Jonathan Ambut, Nujen C Bozkurt, Ana M Alvarez
Frontiers in Clinical Diabetes and Healthcare. 2023-01-01

Journal Articles

Insulin-Mimetic Effects of Short-Term Rapamycin in Type 1 Diabetic Patients Prior to Islet Transplantation
Rodolfo Alejandro, MD, Acta Diabetologica

Press Mentions

Can Stem Cell Therapy Disrupt Type 1 Diabetes Treatment Paradigm—or Even Cure the Disease? University of Miami Launches a Study to Discover This AnswerApril 7th, 2021
Long-Term Islet Transplant Recipients Show near-Normal Glucose ControlJune 8th, 2019
DRI Poseidon Trial Recruiting Children and AdultsMarch 5th, 2019
Join now to see all